Several U.S. states are moving to block lawsuits against Bayer over its glyphosate-based herbicide, Roundup. But if it’s truly safe, why the legal shields? And who are lawmakers really looking out for?
A $611 million U.S. court verdict over Roundup and cancer risks raises urgent questions for New Zealand. Are we protecting public health—or protecting industry?
Part investigative exposé, part cautionary tale—Whitewash pulls back the curtain on one of the world’s most widely used herbicides, revealing a disturbing pattern of corporate manipulation and scientific denial.
If Bayer collapses under legal pressure, what happens to the glyphosate market? Will farmers and homeowners face a flood of low-quality imports? Let’s explore the potential fallout.
Is Bayer’s legal strategy about risk management — or keeping critical evidence out of the public eye? We examine the tactics behind settling Roundup lawsuits.
Bayer keeps settling lawsuits over Roundup, even while insisting glyphosate is safe. Is it about protecting public perception or minimizing financial risk?
Bayer’s acquisition of Monsanto brought with it a legal nightmare — thousands of lawsuits alleging that Roundup causes cancer. As settlements climb into the billions, Bayer’s fight for damage control raises crucial questions about corporate accountability and public health.
Carey Gillam’s The Monsanto Papers exposes the legal battles behind glyphosate, shedding light on corporate secrecy, scientific manipulation, and one man’s fight for justice.
